Therapeutic Asset Ratings
278 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pexidartinib
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Pexidartinib
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Rilvegostomig
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Rilvegostomig
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Rilvegostomig
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Sarilumab
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Sarilumab
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Sarilumab
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Trastuzumab Duocarmazine
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Trastuzumab Duocarmazine
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Trebananib
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Trebananib
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Trilaciclib
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Trilaciclib
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Veliparib
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Veliparib
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Vepdegestrant
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Vepdegestrant
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
vv1
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
vv1
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
vv1
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Zanidatamab
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CCC
(48)
Ganetespib
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CC
(47)
Ganetespib
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare Collaborative
P2
CC
(47)
mk-2206
Breast Neoplasm
QuantumLeap Healthcare Collaborative
P2
CC
(47)
Showing 176 to 200 of 278 assets
Previous
Page 8 of 12
Next
